Biotech Stocks

Court halts Colorado price cap on Amgen's blockbuster Enbrel

Endpoints News 6h ago 70% Move

US District Court Judge Daniel Domenico in Colorado granted Amgen's preliminary injunction to stop a 70% price cap on its blockbuster autoimmune drug Enbrel, arguing that the cap could cause "economic injury" to the company ...

Discussion

Sign in to join the discussion. Comments loading…